Aerovate Therapeutics (AVTE) Stock Chart & Stock Price History $2.57 -0.02 (-0.77%) Closing price 02/4/2025 04:00 PM EasternExtended Trading$2.57 +0.00 (+0.16%) As of 02/4/2025 04:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Aerovate Therapeutics Stock Price Performance 5 Day Performance-1.91%1 Month Performance-4.10%3 Month Performance-4.81%6 Month Performance+56.71%Year-To-Date Performance-3.02%1 Year Performance-85.83% Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address AVTE Stock Chart for Wednesday, February, 5, 2025 AVTE Chart by TradingView Aerovate Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/04/2025$2.59$2.57-0.77%$2.68$2.5267,155 shs$74.22 million02/03/2025$2.62$2.59-1.15%$2.64$2.56100,886 shs$74.80 million01/31/2025$2.62$2.62$2.70$2.56141,621 shs$75.65 million01/30/2025$2.58$2.62+1.55%$2.64$2.55125,806 shs$75.67 million01/29/2025$2.46$2.58+4.88%$2.61$2.44597,764 shs$74.51 million01/28/2025$2.57$2.46-4.28%$2.55$2.44506,496 shs$71.05 million01/27/2025$2.59$2.57-0.77%$2.67$2.55107,596 shs$74.21 million01/24/2025$2.56$2.59+1.17%$2.63$2.5382,259 shs$74.80 million01/23/2025$2.53$2.56+1.19%$2.58$2.4681,767 shs$73.93 million01/22/2025$2.55$2.53-0.78%$2.57$2.48152,747 shs$73.07 million Get the Latest News and Ratings for AVTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 01/21/2025$2.58$2.55-1.16%$2.57$2.45318,353 shs$73.64 million01/20/2025$2.58$2.58$2.60$2.44249,881 shs$74.51 million01/17/2025$2.43$2.58+6.17%$2.60$2.44249,881 shs$74.51 million01/16/2025$2.46$2.43-1.22%$2.52$2.40104,616 shs$70.18 million01/15/2025$2.46$2.46$2.49$2.45275,476 shs$71.03 million01/14/2025$2.50$2.46-1.60%$2.51$2.43627,496 shs$71.03 million01/13/2025$2.55$2.50-1.96%$2.55$2.49223,144 shs$72.19 million01/10/2025$2.64$2.55-3.41%$2.64$2.50844,176 shs$73.63 million01/09/2025$2.64$2.64$2.68$2.58124,365 shs$76.23 million01/08/2025$2.68$2.64-1.49%$2.68$2.58124,365 shs$76.23 million01/07/2025$2.70$2.68-0.74%$2.71$2.6586,945 shs$77.39 million01/06/2025$2.68$2.70+0.75%$2.71$2.68280,555 shs$77.96 million Related Companies Eyenovia Stock Chart enGene Stock Chart COMPASS Pathways Stock Chart Voyager Therapeutics Stock Chart biote Stock Chart Immutep Stock Chart 4D Molecular Therapeutics Stock Chart Benitec Biopharma Stock Chart LifeVantage Stock Chart iTeos Therapeutics Stock Chart Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVTE) was last updated on 2/5/2025 by MarketBeat.com Staff From Our PartnersNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHe called the top and bottom of Bitcoin nearly to the day … Here’s what he says is next.With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNew crypto boom will be greatest in historyUrgent Notice from Ian King, the Crypto Expert Who Made 18,325% in a Year: “Donald Trump’s second term is t...Banyan Hill Publishing | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aerovate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
